Skip to main content
SpringerLink
Log in

Growth hormone treatment started in the first year of life in infants with chronic renal failure

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Infants with chronic renal failure (CRF) are at high risk of experiencing severe growth retardation. We report a study of 12 infants with CRF who have been treated with recombinant human growth hormone (rhGH) since the age of 0.5 ± 0.3 years. A control group comprised 15 infants with less severe CRF who were being treated during the same period, but who did not receive rhGH. Despite the infants in the rhGH group had more severe renal failure, they grew at least as well as those in the control group and experienced catch-up growth that started earlier and was more sustained; they also gained more weight. Between the age of 0.5 and 2.5 years, the height standard deviation score (HtSDS) improved from −2.0 ± 1.2 to −0.9 ± 0.9 in the rhGH group (p < 0.005) and from −1.6 ± 1.6 to −1.0 ± 1.9 in the control group (p=non significant, n.s.). The average gain in HtSDS was +1.1 ± 0.8 in the treated group and +0.6 ± 1.4 in the control group (p = n.s.). During the same period, the weight SDS improved from −2.2 ± 0.9 to −0.6 ± 1.2 (p < 0.005) and from −1.9 ± 1.2 to −1.3 ± 1.2 (p=n.s.) in the treatment and control groups, respectively. Nutritional intake was similar in both groups, while parathyroid hormone levels tended to increase, although not significantly, after rhGH treatment (p=n.s.). The results of this pilot study suggest that very early treatment with rhGH in patients with early-onset CRF may improve growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German study group for growth hormone treatment in chronic renal failure. N Engl J Med 343:923–930

    Article  CAS  Google Scholar 

  2. Mahan JD, Warady BA (2008) Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol 21:917–930

    Article  Google Scholar 

  3. Mahesh S, Kaskel F (2008) Growth hormone axis in chronic kidney disease. Pediatr Nephrol 23:41–48

    Article  Google Scholar 

  4. Kleinknecht C, Broyer M, Huot M, Marti-Henneberg C, Dartois AM (1983) Growth and development of nondialyzed children with chronic renal failure. Kidney Int 24[Suppl 15]:S40–S47

    Google Scholar 

  5. Rees L, Rigden SPA, Ward GM (1989) Chronic renal failure and growth. Arch Dis Child 64:573–577

    Article  CAS  Google Scholar 

  6. Fine RN, Kohaut E, Brown D, Kuntze J, Attie KM (1996) Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. Kidney Int 49:781–785

    Article  CAS  Google Scholar 

  7. Vimalachandra D, Craig JC, Cowell CT, Knight JF (2001) Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. J Pediatr 139:560–567

    Article  CAS  Google Scholar 

  8. Maxwell H, Rees L (1996) Recombinant human growth hormone treatment in infants with chronic renal failure. Arch Dis Child 74:40–43

    Article  CAS  Google Scholar 

  9. Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J (2000) Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 14:701–706

    Article  CAS  Google Scholar 

  10. Tonshoff B, Mehls O (1995) Growth retardation in children with chronic renal insufficiency: current aspects of pathophysiology and treatment. J Nephrol 8:133–142

    Google Scholar 

  11. Kaskel F (2003) Chronic renal disease: a growing problem. Kidney Int 64:1141–1151

    Article  Google Scholar 

  12. Karlberg J, Schaefer F, Hennicke M, Wingen AM, Rigden S, Mehls O (1996) Early age-dependent growth impairment in chronic renal failure. European study group for nutritional treatment of chronic renal failure in childhood. Pediatr Nephrol 10:283–287

    Article  CAS  Google Scholar 

  13. Van Dyck M, Sidler S, Proesmans W (1998) Chronic renal failure in infants: effect of strict conservative treatment on growth. Eur J Pediatr 157:759–762

    Article  Google Scholar 

  14. Kopple JD, National Kidney Foundation K/DOQI Work Group (2001) The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients. Am J Kidney Dis 38[Suppl 1]:S68–S73

    Article  CAS  Google Scholar 

  15. United States growth charts. National Center for Health Statistics, Center for Disease Control. Available at https://doi.org/www.cdc.gov/nchs/about/major/nhanes/growthcharts/datafiles.htm

  16. Guerlich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press, Stanford, California

    Book  Google Scholar 

  17. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590

    Article  CAS  Google Scholar 

  18. Fine RN, Attie KM, Kuntze J, Brown DF, Kohaut EC (1995) Recombinant human growth hormone in infants and young children with chronic renal insufficiency: Genentech Collaborative Study Group. Pediatr Nephrol 9:451–457

    Article  CAS  Google Scholar 

  19. Kari JA, Gonzalez C, Ledermann SE, Shaw V, Rees L (2000) Outcome and growth of infants with severe chronic renal failure. Kidney Int 57:1681–1687

    Article  CAS  Google Scholar 

  20. Fine RN, Ho M, Tejani A, Blethen S (2003) Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 142:539–545

    Article  CAS  Google Scholar 

  21. Bérard E, Crosnier H, Six-Beneton A, Chevallier T, Cochat P, Broyer M (1998) Recombinant human growth hormone treatment of children on hemodialysis. French Society of Pediatric Nephrology. Pediatr Nephrol 12:304–310

    Article  Google Scholar 

  22. Maxwell H, Rees L (1998) Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British association for pediatric nephrology. Arch Dis Child 79:481–487

    Article  CAS  Google Scholar 

  23. Picca S, Cappa M, Martinez C, Moges SI, Osborn J, Perfumo F, Ardissino G, Bonaudo R, Montini G, Rizzoni G (2004) Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone. Pediatr Nephrol 19:71–76

    Article  Google Scholar 

  24. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105

    Article  Google Scholar 

  25. Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 10:1426–1433

    Article  Google Scholar 

  26. Rees L (2008) What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr Nephrol 23:179–184

    Article  Google Scholar 

  27. Silverstein DM, Kher KK, Moudgil A, Khurana M, Wilcox J, Moylan K (2008) Cinacalcet is efficacious in pediatric dialysis patients. Pediatr Nephrol 23:1817–1822

    Article  Google Scholar 

  28. Muscheites J, Wigger M, Drueckler E, Fischer DC, Kundt G, Haffner D (2008) Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease. Pediatr Nephrol 23:1823–1829

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology and Urology, Division of Nephrology and Dialysis, Bambino Gesù Children’s Hospital and Research Institute (IRCCS), Piazza S. Onofrio, 4, 00165, Rome, Italy

    Francesca Mencarelli, Giovanna Leozappa, Gilda Stringini & Francesco Emma

  2. Department of Pediatrics, University of Bologna, Bologna, Italy

    Francesca Mencarelli

  3. Department of Pediatric Medicine - Division of Endocrinology, Bambino Gesù Children’s Hospital and Research Institute, Rome, Italy

    Daniela Kiepe & Marco Cappa

Authors
  1. Francesca Mencarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniela Kiepe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giovanna Leozappa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gilda Stringini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marco Cappa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesco Emma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Emma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mencarelli, F., Kiepe, D., Leozappa, G. et al. Growth hormone treatment started in the first year of life in infants with chronic renal failure. Pediatr Nephrol 24, 1039–1046 (2009). https://doi.org/10.1007/s00467-008-1084-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-008-1084-7

Keywords

Search

Navigation